Login / Signup

Cbl Proto-Oncogene B (CBLB) c.197A>T Mutation Induces Mild Metabolic Dysfunction in Partial Type I Multiple Symmetric Lipomatosis (MSL).

Ke ChenXinxing WanLiling ZhaoShaoli ZhaoLin PengWenjun YangJingjing YuanLiyong ZhuZhao-Hui Mo
Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)
This study analyzed clinical, histopathological, and cellular and molecular biological characterizations of 13 Type I MSL patients and identified the CBLB c.197A>T heterozygous mutation that could be responsible for MSL metabolic dysfunction or even MSL development.
Keyphrases
  • end stage renal disease
  • oxidative stress
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • patient reported outcomes